Publication | Open Access
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
284
Citations
10
References
2020
Year
The combination regimen of nivolumab plus ipilimumab demonstrates activity in metastatic uveal melanoma, with deep and sustained confirmed responses.
| Year | Citations | |
|---|---|---|
Page 1
Page 1